LFLT mit Bomben-News ! - 500 Beiträge pro Seite

[tom2006]

Lifeline Therapeutics, Inc. Announces Distribution of Protandim(R) in CVS/Pharmacy Stores Nationwide

Lifeline Therapeutics, Inc. (OTCBB: LFLT) today announced that Protandim(R) will be carried in CVS/pharmacy stores nationwide beginning in August. Protandim, a dietary supplement clinically proven to increase the body's natural antioxidant defenses and combat oxidative stress, will be sold at more than 6,100 locations in the CVS drugstore chain throughout the U.S., including the Sav-on and Osco stores recently acquired by CVS.

"By making Protandim available at CVS/pharmacy, we've greatly expanded our reach and are able to offer more customers the cellular health and healthy aging benefits of this fundamentally new approach to antioxidant therapy," said Stephen Onody, Lifeline Therapeutics CEO. "Through the CVS partnership, the availability of Protandim will be significantly increased."

As a part of the launch, CVS/pharmacy will co-market Protandim through a variety of initiatives, including national print advertisements in over 800 publications, in-store signage, and off-shelf merchandising. Lifeline also plans to offer a Continuing Medical Education program to CVS pharmacists.

About Protandim(R)

Protandim(R) is a patent-pending dietary supplement that increases the body's natural antioxidant protection by inducing two protective enzymes, superoxide dismustase (SOD) and catalase (CAT). These naturally occurring enzymes simply become overwhelmed by free radicals as we get older. Oxidative stress (cell damage caused by free radicals) occurs as a person ages, when subjected to environmental stresses or as an associated factor in certain illnesses. TBARS are laboratory markers for oxidative stress in the body. New data from a scientific study in men and women show that after 30 days of taking Protandim(R), the level of circulating TBARS decreased an average of 40 percent, with this decrease shown to be maintained at 120 days. Protandim(R) strengthens a person's defenses against oxidative stress by increasing the body's natural antioxidant enzymes. For more information, please visit the Protandim(R) product web site at www.protandim.com.

About Lifeline Therapeutics, Inc.

Lifeline Therapeutics, Inc. markets Protandim(R). Lifeline Therapeutics is committed to helping people achieve health and wellness for life. For more information, please visit the Company's web site at www.lifelinetherapeutics.com.

About CVS/pharmacy

CVS/pharmacy, America's largest retail pharmacy, is committed to serving the healthcare needs of all customers by being the easiest pharmacy for customers to use, both in its 6,100+ stores and online at CVS.com. General information about CVS is available at http://investor.cvs.com, as well as www.cvs.com/pressroom.

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable common law. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences include the Company's limited cash flow and the rapid development of technology, lack of liquidity for the Company's common stock, working capital shortages, the length of time for scientific advances to reach the market (if they ever reach the market), among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.

Lifeline Therapeutics, Inc.
Stephen K. Onody, 720-488-1711
or
Gerald J. Houston, 720-488-1711
Fax: [phone]
or
LeGrand Hart
Erin Ragan, 303-298-8470
or
Hannah Shawcross, 303-298-8470
Fax: [phone]


Source: Business Wire (July 17, 2006 - 4:06 PM EDT)

News by QuoteMedia
www.quotemedia.com

[tom2006]

float etwas über 7 mio...
52wkhigh bei 11.94
was bleibt noch zu sagen?
steigt erst ein wenn ich schon drin bin...
das wird heiss morgen
viel glück

[bauspara]

Protandim May Slow Aging Process by Increasing Enzymes That Fight Free Radicals

June 2, 2005 -- Dr. Joe McCord's latest research may unravel the mystery of aging. And if he succeeds, the answer could come in the form of a little yellow pill called Protandim.

The University of Colorado at Denver biochemistry professor has conducted decades of experiments into a special class of enzymes in the cell that some hope have the potential of extending lives and possibly preventing chronic diseases like cancer, diabetes and heart disease.

Much of his work has centered on oxidative stress — which increases with age. TBARS, which are a measure of oxidative stress, can also be a rough indicator of a person's actual age.

But, McCord has found that the ingredients in Protandim lowered the test subject's level of oxidative stress.

"They all are reduced to the level of oxidative stress that one would expect, frankly, in a newborn. Or a very young child,' he said.

Dangerous Radicals

To be sure, there have been other supposed "miracle" drugs and treatments that never delivered on their promise to delay or even stop human aging. But McCord, research director in the company that makes Protandim, believes this pill might be different.

To understand how Protandim works, you have to first understand how aging occurs.

Aging is "a slow progression of oxidative stress," McCord said. Much of oxidative stress comes from the basic function of eating.

As cells burn food, they also release toxic chemicals known as "free radicals" which cause cell damage and consequently — oxidative stress.

The body fights back by making two anti-oxidant enzymes — Catalase and SOD. But as people get older, those enzymes can get overwhelmed.

For a long time, scientists thought that anti-oxidant vitamins like C and E could lower oxidation, but many experts now believe they aren't effective.

Protandim, McCord said, is much more powerful. Tests on both mice and humans have already shown that it revs up the body's manufacture of those enzymes — thereby reducing the presence of those harmful free radicals.

http://abcnews.go.com/Primetime/Health/story?id=814805&page=…